IDEAS home Printed from https://ideas.repec.org/a/eee/hepoli/v124y2020i4p411-418.html
   My bibliography  Save this article

Out of pocket or out of control: A qualitative analysis of healthcare professional stakeholder involvement in pharmaceutical policy change in Ireland

Author

Listed:
  • O’Brien, Gary L.
  • Sinnott, Sarah-Jo
  • O’ Flynn, Bridget
  • Walshe, Valerie
  • Mulcahy, Mark
  • Byrne, Stephen

Abstract

Mandatory co-payments attached to prescription medicines on the Irish public health insurance [General Medical Services (GMS)] scheme have undergone multiple iterations since their introduction in October 2010. To date, whilst patients’ opinions on said co-payments have been evaluated, the perspectives of community pharmacists and general practitioners (GPs) have not.

Suggested Citation

  • O’Brien, Gary L. & Sinnott, Sarah-Jo & O’ Flynn, Bridget & Walshe, Valerie & Mulcahy, Mark & Byrne, Stephen, 2020. "Out of pocket or out of control: A qualitative analysis of healthcare professional stakeholder involvement in pharmaceutical policy change in Ireland," Health Policy, Elsevier, vol. 124(4), pages 411-418.
    • Handle: RePEc:eee:hepoli:v:124:y:2020:i:4:p:411-418
    DOI: 10.1016/j.healthpol.2020.02.011
    as

    Download full text from publisher

    File URL: http://www.sciencedirect.com/science/article/pii/S0168851020300464
    Download Restriction: Full text for ScienceDirect subscribers only
    File URL: https://libkey.io/10.1016/j.healthpol.2020.02.011?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    as
    1. Naimi Johansson & Niklas Jakobsson & Mikael Svensson, 2019. "Effects of primary care cost-sharing among young adults: varying impact across income groups and gender," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 20(8), pages 1271-1280, November.
    2. Harry Comber & Marianna De Camargo Cancela & Trutz Haase & Howard Johnson & Linda Sharp & Jonathan Pratschke, 2016. "Affluence and Private Health Insurance Influence Treatment and Survival in Non-Hodgkin’s Lymphoma," PLOS ONE, Public Library of Science, vol. 11(12), pages 1-14, December.
    3. Doran, Evan & Robertson, Jane & Henry, David, 2005. "Moral hazard and prescription medicine use in Australia--the patient perspective," Social Science & Medicine, Elsevier, vol. 60(7), pages 1437-1443, April.
    4. Laia Maynou & Gabriel Coll-de-Tuero & Marc Saez, 2019. "The effects of copayment in primary health care: evidence from a natural experiment," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 20(8), pages 1237-1248, November.
    5. Philipp Hafner & Jörg C. Mahlich, 2016. "Determinants of physician's office visits and potential effects of co-payments: evidence from Austria," International Journal of Health Planning and Management, Wiley Blackwell, vol. 31(3), pages 192-203, July.
    6. M. Fasihul Alam & David Cohen & Frank Dunstan & Dyfrig Hughes & Philip Routledge, 2018. "Impact of the phased abolition of co‐payments on the utilisation of selected prescription medicines in Wales," Health Economics, John Wiley & Sons, Ltd., vol. 27(1), pages 236-243, January.
    7. Maynou, Laia & Coll-de-Tuero, Gabriel & Saez, Marc, 2019. "The effects of copayment in primary health care: evidence from a natural experiment," LSE Research Online Documents on Economics 101303, London School of Economics and Political Science, LSE Library.
    8. Elka Atanasova & Milena Pavlova & Emanuela Moutafovа & Todorka Kostadinova & Wim Groot, 2015. "Patient charges for health services: the opinions of healthcare stakeholders in Bulgaria," International Journal of Health Planning and Management, Wiley Blackwell, vol. 30(3), pages 232-245, July.
    9. Burke, Sara & Barry, Sarah & Siersbaek, Rikke & Johnston, Bridget & Ní Fhallúin, Maebh & Thomas, Steve, 2018. "Sláintecare – A ten-year plan to achieve universal healthcare in Ireland," Health Policy, Elsevier, vol. 122(12), pages 1278-1282.
    10. Kasje, W. N. & Timmer, J. W. & Boendermaker, P. M. & Haaijer-Ruskamp, F. M., 2002. "Dutch GPs' perceptions: the influence of out-of-pocket costs on prescribing," Social Science & Medicine, Elsevier, vol. 55(9), pages 1571-1578, November.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Berger, Michael & Six, Eva & Czypionka, Thomas, 2024. "Policy implications of heterogeneous demand reactions to changes in cost-sharing: patient-level evidence from Austria," LSE Research Online Documents on Economics 121162, London School of Economics and Political Science, LSE Library.
    2. Ellegård, Lina Maria & Kjellsson, Gustav & Mattisson, Linn, 2021. "An App Call a Day Keeps the Patient Away? Substitution of Online and In-Person Doctor Consultations Among Young Adults," Working Papers in Economics 808, University of Gothenburg, Department of Economics, revised May 2022.
    3. Ma, Yuanyuan & Nolan, Anne & Smith, James P., 2020. "Free GP care and psychological health: Quasi-experimental evidence from Ireland," Journal of Health Economics, Elsevier, vol. 72(C).
    4. Loukas Balafoutas & Rudolf Kerschbamer & Matthias Sutter, 2017. "Second‐Degree Moral Hazard In A Real‐World Credence Goods Market," Economic Journal, Royal Economic Society, vol. 127(599), pages 1-18, February.
    5. Paraponaris, A. & Verger, P. & Desquins, B. & Villani, P. & Bouvenot, G. & Rochaix, L. & Gourheux, J. C. & Moatti, J. P. AU -, 2004. "Delivering generics without regulatory incentives?: Empirical evidence from French general practitioners about willingness to prescribe international non-proprietary names," Health Policy, Elsevier, vol. 70(1), pages 23-32, October.
    6. Carlsen, Benedicte & Hole, Arne Risa & Kolstad, Julie Riise & Norheim, Ole Frithjof, 2012. "When you can’t have the cake and eat it too," Social Science & Medicine, Elsevier, vol. 75(11), pages 1964-1973.
    7. Johnston, Bridget M. & Burke, Sara & Barry, Sarah & Normand, Charles & Ní Fhallúin, Maebh & Thomas, Steve, 2019. "Private health expenditure in Ireland: Assessing the affordability of private financing of health care," Health Policy, Elsevier, vol. 123(10), pages 963-969.
    8. Pedersen, Line Bjørnskov & Hess, Stephane & Kjær, Trine, 2016. "Asymmetric information and user orientation in general practice: Exploring the agency relationship in a best–worst scaling study," Journal of Health Economics, Elsevier, vol. 50(C), pages 115-130.
    9. McDonnell, Thérèse & Nicholson, Emma & Bury, Gerard & Collins, Claire & Conlon, Ciara & Denny, Kevin & O'Callaghan, Michael & McAuliffe, Eilish, 2022. "Policy of free GP care for children under 6 years: The impact on daytime and out-of-hours general practice," Social Science & Medicine, Elsevier, vol. 296(C).
    10. Goldsmith, Laurie J. & Kolhatkar, Ashra & Popowich, Dominic & Holbrook, Anne M. & Morgan, Steven G. & Law, Michael R., 2017. "Understanding the patient experience of cost-related non-adherence to prescription medications through typology development and application," Social Science & Medicine, Elsevier, vol. 194(C), pages 51-59.
    11. Fraeyman, Jessica & Symons, Linda & De Loof, Hans & De Meyer, Guido R.Y. & Remmen, Roy & Beutels, Philippe & Van Hal, Guido, 2015. "Medicine price awareness in chronic patients in Belgium," Health Policy, Elsevier, vol. 119(2), pages 217-223.
    12. Hirotaka Kato & Rei Goto & Taishi Tsuji & Katsunori Kondo, 2022. "The effects of patient cost-sharing on health expenditure and health among older people: Heterogeneity across income groups," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 23(5), pages 847-861, July.
    13. Ann, Kirby & Murphy, Aileen, 2022. "Would universal general practitioner care impact Irish adolescents’ utilisation?," Health Policy, Elsevier, vol. 126(7), pages 652-660.
    14. Thomas, Steve & Johnston, Bridget & Barry, Sarah & Siersbaek, Rikke & Burke, Sara, 2021. "Sláintecare implementation status in 2020: Limited progress with entitlement expansion," Health Policy, Elsevier, vol. 125(3), pages 277-283.
    15. Antonio Palazón-Bru & Miriam Calvo-Pérez & Pilar Rico-Ferreira & María Anunciación Freire-Ballesta & Vicente Francisco Gil-Guillén & María de los Ángeles Carbonell-Torregrosa, 2021. "Influence of Pharmaceutical Copayment on Emergency Hospital Admissions: A 1978–2018 Time Series Analysis in Spain," IJERPH, MDPI, vol. 18(15), pages 1-12, July.
    16. Kelleher, Dan & Doherty, Edel & O'Neill, Ciaran, 2022. "Examining the transnational preventive healthcare utilisation of a group of Eastern European migrants living full-time in another European state," Health Policy, Elsevier, vol. 126(4), pages 318-324.
    17. Burke, Sara & McGettrick, Grainne & Foley, Karen & Manikandan, Manjula & Barry, Sarah, 2020. "The 2019 neuro-rehabilitation implementation framework in Ireland: Challenges for implementation and the implications for people with brain injuries," Health Policy, Elsevier, vol. 124(3), pages 225-230.
    18. Mamas Theodorou, 2014. "Testing the Waters for GeSY: Patients’ Opinion of Cost-sharing Arrangements in the Public Health Care System in Cyprus," Cyprus Economic Policy Review, University of Cyprus, Economics Research Centre, vol. 8(2), pages 37-59, December.
    19. Lopes, Francisca Vargas & Riumallo Herl, Carlos J. & Mackenbach, Johan P. & Van Ourti, Tom, 2022. "Patient cost-sharing, mental health care and inequalities: A population-based natural experiment at the transition to adulthood," Social Science & Medicine, Elsevier, vol. 296(C).
    20. Timothy Bolt & Hisanori Kobayashi & Jörg Mahlich, 2019. "Patient and Physician Preferences for Therapy Characteristics for Psoriasis: A Discrete Choice Experiment in Japan," PharmacoEconomics - Open, Springer, vol. 3(2), pages 255-264, June.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:eee:hepoli:v:124:y:2020:i:4:p:411-418. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Catherine Liu or the person in charge (email available below). General contact details of provider: http://www.elsevier.com/locate/healthpol .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.